Marshall Wace, LLP Maia Biotechnology, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 16,165 shares of MAIA stock, worth $26,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,165Holding current value
$26,833% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
2.26MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.14MShares$1.89 Million0.0% of portfolio
-
Centric Wealth Management573KShares$951,8400.26% of portfolio
-
Geode Capital Management, LLC Boston, MA222KShares$368,8230.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$130,3440.0% of portfolio
-
State Street Corp Boston, MA75.6KShares$125,4130.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $18.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...